Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

541 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The case for adjuvant chemotherapy in pancreatic cancer.
Ghaneh P, Sultana A, Shore S, Stocken D, Neoptolemos J. Ghaneh P, et al. Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):383-401. doi: 10.1016/j.bpg.2005.11.008. Best Pract Res Clin Gastroenterol. 2006. PMID: 16549334 Review.
Adjuvant therapy for pancreatic cancer.
Ghaneh P, Slavin J, Sutton R, Neoptolemos JP. Ghaneh P, et al. Among authors: neoptolemos jp. Swiss Surg. 2000;6(5):289-95. doi: 10.1024/1023-9332.6.5.289. Swiss Surg. 2000. PMID: 11077498 Review.
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. Lancet. 2001 Nov 10;358(9293):1576-85. doi: 10.1016/s0140-6736(01)06651-x. Lancet. 2001. PMID: 11716884 Clinical Trial.
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.
Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, Bassi C, Dervenis C, Fernandez-Cruz L, Lacaine F, Buckels J, Deakin M, Adab FA, Sutton R, Imrie C, Ihse I, Tihanyi T, Olah A, Pedrazzoli S, Spooner D, Kerr DJ, Friess H, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. Ann Surg. 2001 Dec;234(6):758-68. doi: 10.1097/00000658-200112000-00007. Ann Surg. 2001. PMID: 11729382 Free PMC article. Clinical Trial.
[Adjuvant and additive therapy for cancer of the pancreas].
Neoptolemos JP, Raraty MG, Ghaneh P, Hickey H, Stocken DD, Dunn JA, Friess H, Büchler MW. Neoptolemos JP, et al. Chirurg. 2003 Mar;74(3):191-201. doi: 10.1007/s00104-003-0614-x. Chirurg. 2003. PMID: 12647075 Review. German.
Adjuvant therapy in pancreatic cancer: historical and current perspectives.
Neoptolemos JP, Cunningham D, Friess H, Bassi C, Stocken DD, Tait DM, Dunn JA, Dervenis C, Lacaine F, Hickey H, Raraty MG, Ghaneh P, Büchler MW. Neoptolemos JP, et al. Ann Oncol. 2003 May;14(5):675-92. doi: 10.1093/annonc/mdg207. Ann Oncol. 2003. PMID: 12702520 Free article. Review.
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
Stocken DD, Büchler MW, Dervenis C, Bassi C, Jeekel H, Klinkenbijl JH, Bakkevold KE, Takada T, Amano H, Neoptolemos JP; Pancreatic Cancer Meta-analysis Group. Stocken DD, et al. Among authors: neoptolemos jp. Br J Cancer. 2005 Apr 25;92(8):1372-81. doi: 10.1038/sj.bjc.6602513. Br J Cancer. 2005. PMID: 15812554 Free PMC article.
Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial.
Bassi C, Stocken DD, Olah A, Friess H, Buckels J, Hickey H, Dervenis C, Dunn JA, Deakin M, Carter R, Ghaneh P, Neoptolemos JP, Buchler MW; European Study Group for Pancreatic Cancer (ESPAC). Bassi C, et al. Among authors: neoptolemos jp. Dig Surg. 2005;22(5):353-63. doi: 10.1159/000089771. Epub 2005 Nov 16. Dig Surg. 2005. PMID: 16293966 Clinical Trial.
541 results